aluates Reports

$ 0.0

Automative

Global Antisense Oligonucleotides Drugs for ATTR Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-21D17971

BUY CHAPTERS

Global Antisense Oligonucleotides Drugs for ATTR Market Research Report 2024

Code: QYRE-Auto-21D17971

Report

August 2024

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

ASO

Akcea Therapeutics

Astrazeneca plc

Ionis Pharmaceuticals

Antisense Oligonucleotides Drugs for ATTR Market

Antisense oligonucleotide(ASO)drugs represent a groundbreaking approach for treating transthyretin amyloidosis(ATTR),a condition characterized by the accumulation of misfolded transthyretin proteins that lead to organ damage.These ASO drugs work by targeting and degrading the mRNA that encodes for transthyretin,thus reducing its production at the source.

The global Antisense Oligonucleotides Drugs for ATTR market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Antisense Oligonucleotides Drugs for ATTR is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Antisense Oligonucleotides Drugs for ATTR is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Antisense Oligonucleotides Drugs for ATTR include Akcea Therapeutics, AstraZeneca, Ionis Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antisense Oligonucleotides Drugs for ATTR, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Oligonucleotides Drugs for ATTR.

The Antisense Oligonucleotides Drugs for ATTR market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Antisense Oligonucleotides Drugs for ATTR market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antisense Oligonucleotides Drugs for ATTR manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antisense Oligonucleotides Drugs for ATTR Market Report

Report Metric	Details
Report Name	Antisense Oligonucleotides Drugs for ATTR Market
Segment by Type	Inotersen Eplontersen Other
Segment by Application	Hospital and Clinic Retail Pharmacies Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Akcea Therapeutics, AstraZeneca, Ionis Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antisense Oligonucleotides Drugs for ATTR manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antisense Oligonucleotides Drugs for ATTR in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antisense Oligonucleotides Drugs for ATTR Market report?

Ans: The main players in the Antisense Oligonucleotides Drugs for ATTR Market are Akcea Therapeutics, AstraZeneca, Ionis Pharmaceuticals

What are the Application segmentation covered in the Antisense Oligonucleotides Drugs for ATTR Market report?

Ans: The Applications covered in the Antisense Oligonucleotides Drugs for ATTR Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Antisense Oligonucleotides Drugs for ATTR Market report?

Ans: The Types covered in the Antisense Oligonucleotides Drugs for ATTR Market report are Inotersen, Eplontersen, Other

Recommended Reports

Nucleic Acid Drugs

Amyloidosis & ATTR Therapies

Gene & RNA Therapies

1 Antisense Oligonucleotides Drugs for ATTR Market Overview

1.1 Product Definition

1.2 Antisense Oligonucleotides Drugs for ATTR by Type

1.2.1 Global Antisense Oligonucleotides Drugs for ATTR Market Value Comparison by Type (2024-2030)

1.2.2 Inotersen

1.2.3 Eplontersen

1.2.4 Other

1.3 Antisense Oligonucleotides Drugs for ATTR by Application

1.3.1 Global Antisense Oligonucleotides Drugs for ATTR Market Value by Application (2024-2030)

1.3.2 Hospital and Clinic

1.3.3 Retail Pharmacies

1.3.4 Other

1.4 Global Antisense Oligonucleotides Drugs for ATTR Market Size Estimates and Forecasts

1.4.1 Global Antisense Oligonucleotides Drugs for ATTR Revenue 2019-2030

1.4.2 Global Antisense Oligonucleotides Drugs for ATTR Sales 2019-2030

1.4.3 Global Antisense Oligonucleotides Drugs for ATTR Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Antisense Oligonucleotides Drugs for ATTR Market Competition by Manufacturers

2.1 Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Manufacturers (2019-2024)

2.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Antisense Oligonucleotides Drugs for ATTR Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Antisense Oligonucleotides Drugs for ATTR, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Product Type & Application

2.7 Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Date of Enter into This Industry

2.8 Global Antisense Oligonucleotides Drugs for ATTR Market Competitive Situation and Trends

2.8.1 Global Antisense Oligonucleotides Drugs for ATTR Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Antisense Oligonucleotides Drugs for ATTR Players Market Share by Revenue

2.8.3 Global Antisense Oligonucleotides Drugs for ATTR Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Antisense Oligonucleotides Drugs for ATTR Market Scenario by Region

3.1 Global Antisense Oligonucleotides Drugs for ATTR Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Antisense Oligonucleotides Drugs for ATTR Sales by Region: 2019-2030

3.2.1 Global Antisense Oligonucleotides Drugs for ATTR Sales by Region: 2019-2024

3.2.2 Global Antisense Oligonucleotides Drugs for ATTR Sales by Region: 2025-2030

3.3 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region: 2019-2030

3.3.1 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region: 2019-2024

3.3.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region: 2025-2030

3.4 North America Antisense Oligonucleotides Drugs for ATTR Market Facts & Figures by Country

3.4.1 North America Antisense Oligonucleotides Drugs for ATTR Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Antisense Oligonucleotides Drugs for ATTR Sales by Country (2019-2030)

3.4.3 North America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Antisense Oligonucleotides Drugs for ATTR Market Facts & Figures by Country

3.5.1 Europe Antisense Oligonucleotides Drugs for ATTR Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Antisense Oligonucleotides Drugs for ATTR Sales by Country (2019-2030)

3.5.3 Europe Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Antisense Oligonucleotides Drugs for ATTR Market Facts & Figures by Region

3.6.1 Asia Pacific Antisense Oligonucleotides Drugs for ATTR Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Antisense Oligonucleotides Drugs for ATTR Sales by Region (2019-2030)

3.6.3 Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Antisense Oligonucleotides Drugs for ATTR Market Facts & Figures by Country

3.7.1 Latin America Antisense Oligonucleotides Drugs for ATTR Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Antisense Oligonucleotides Drugs for ATTR Sales by Country (2019-2030)

3.7.3 Latin America Antisense Oligonucleotides Drugs for ATTR Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Market Facts & Figures by Country

3.8.1 Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Sales by Country (2019-2030)

3.8.3 Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Antisense Oligonucleotides Drugs for ATTR Sales by Type (2019-2030)

4.1.1 Global Antisense Oligonucleotides Drugs for ATTR Sales by Type (2019-2024)

4.1.2 Global Antisense Oligonucleotides Drugs for ATTR Sales by Type (2025-2030)

4.1.3 Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Type (2019-2030)

4.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Type (2019-2030)

4.2.1 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Type (2019-2024)

4.2.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Type (2025-2030)

4.2.3 Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Type (2019-2030)

4.3 Global Antisense Oligonucleotides Drugs for ATTR Price by Type (2019-2030)

5 Segment by Application

5.1 Global Antisense Oligonucleotides Drugs for ATTR Sales by Application (2019-2030)

5.1.1 Global Antisense Oligonucleotides Drugs for ATTR Sales by Application (2019-2024)

5.1.2 Global Antisense Oligonucleotides Drugs for ATTR Sales by Application (2025-2030)

5.1.3 Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Application (2019-2030)

5.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Application (2019-2030)

5.2.1 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Application (2019-2024)

5.2.2 Global Antisense Oligonucleotides Drugs for ATTR Revenue by Application (2025-2030)

5.2.3 Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Application (2019-2030)

5.3 Global Antisense Oligonucleotides Drugs for ATTR Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Akcea Therapeutics

6.1.1 Akcea Therapeutics Company Information

6.1.2 Akcea Therapeutics Description and Business Overview

6.1.3 Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Product Portfolio

6.1.5 Akcea Therapeutics Recent Developments/Updates

6.2 AstraZeneca

6.2.1 AstraZeneca Company Information

6.2.2 AstraZeneca Description and Business Overview

6.2.3 AstraZeneca Antisense Oligonucleotides Drugs for ATTR Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AstraZeneca Antisense Oligonucleotides Drugs for ATTR Product Portfolio

6.2.5 AstraZeneca Recent Developments/Updates

6.3 Ionis Pharmaceuticals

6.3.1 Ionis Pharmaceuticals Company Information

6.3.2 Ionis Pharmaceuticals Description and Business Overview

6.3.3 Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Product Portfolio

6.3.5 Ionis Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Antisense Oligonucleotides Drugs for ATTR Industry Chain Analysis

7.2 Antisense Oligonucleotides Drugs for ATTR Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Antisense Oligonucleotides Drugs for ATTR Production Mode & Process

7.4 Antisense Oligonucleotides Drugs for ATTR Sales and Marketing

7.4.1 Antisense Oligonucleotides Drugs for ATTR Sales Channels

7.4.2 Antisense Oligonucleotides Drugs for ATTR Distributors

7.5 Antisense Oligonucleotides Drugs for ATTR Customers

8 Antisense Oligonucleotides Drugs for ATTR Market Dynamics

8.1 Antisense Oligonucleotides Drugs for ATTR Industry Trends

8.2 Antisense Oligonucleotides Drugs for ATTR Market Drivers

8.3 Antisense Oligonucleotides Drugs for ATTR Market Challenges

8.4 Antisense Oligonucleotides Drugs for ATTR Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

ASO

Akcea Therapeutics

Astrazeneca plc

Ionis Pharmaceuticals

List of Tables

Table 1. Global Antisense Oligonucleotides Drugs for ATTR Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Antisense Oligonucleotides Drugs for ATTR Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Antisense Oligonucleotides Drugs for ATTR Market Competitive Situation by Manufacturers in 2023

Table 4. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Antisense Oligonucleotides Drugs for ATTR Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Antisense Oligonucleotides Drugs for ATTR Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Antisense Oligonucleotides Drugs for ATTR, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Product Type & Application

Table 12. Global Key Manufacturers of Antisense Oligonucleotides Drugs for ATTR, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Antisense Oligonucleotides Drugs for ATTR by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotides Drugs for ATTR as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Antisense Oligonucleotides Drugs for ATTR Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Antisense Oligonucleotides Drugs for ATTR Sales by Region (2019-2024) & (K Units)

Table 18. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Region (2019-2024)

Table 19. Global Antisense Oligonucleotides Drugs for ATTR Sales by Region (2025-2030) & (K Units)

Table 20. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Region (2025-2030)

Table 21. Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Region (2019-2024)

Table 23. Global Antisense Oligonucleotides Drugs for ATTR Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Region (2025-2030)

Table 25. North America Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Antisense Oligonucleotides Drugs for ATTR Sales by Country (2019-2024) & (K Units)

Table 27. North America Antisense Oligonucleotides Drugs for ATTR Sales by Country (2025-2030) & (K Units)

Table 28. North America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Antisense Oligonucleotides Drugs for ATTR Sales by Country (2019-2024) & (K Units)

Table 32. Europe Antisense Oligonucleotides Drugs for ATTR Sales by Country (2025-2030) & (K Units)

Table 33. Europe Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Antisense Oligonucleotides Drugs for ATTR Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Antisense Oligonucleotides Drugs for ATTR Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Type (2019-2024)

Table 51. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Type (2025-2030)

Table 52. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Type (2019-2024)

Table 53. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Type (2025-2030)

Table 54. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Type (2019-2024)

Table 57. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Type (2025-2030)

Table 58. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Type (2019-2024)

Table 59. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Type (2025-2030)

Table 60. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Application (2019-2024)

Table 61. Global Antisense Oligonucleotides Drugs for ATTR Sales (K Units) by Application (2025-2030)

Table 62. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Application (2019-2024)

Table 63. Global Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Application (2025-2030)

Table 64. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Antisense Oligonucleotides Drugs for ATTR Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Application (2019-2024)

Table 67. Global Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Application (2025-2030)

Table 68. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Application (2019-2024)

Table 69. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Application (2025-2030)

Table 70. Akcea Therapeutics Company Information

Table 71. Akcea Therapeutics Description and Business Overview

Table 72. Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Akcea Therapeutics Antisense Oligonucleotides Drugs for ATTR Product

Table 74. Akcea Therapeutics Recent Developments/Updates

Table 75. AstraZeneca Company Information

Table 76. AstraZeneca Description and Business Overview

Table 77. AstraZeneca Antisense Oligonucleotides Drugs for ATTR Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. AstraZeneca Antisense Oligonucleotides Drugs for ATTR Product

Table 79. AstraZeneca Recent Developments/Updates

Table 80. Ionis Pharmaceuticals Company Information

Table 81. Ionis Pharmaceuticals Description and Business Overview

Table 82. Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Ionis Pharmaceuticals Antisense Oligonucleotides Drugs for ATTR Product

Table 84. Ionis Pharmaceuticals Recent Developments/Updates

Table 85. Key Raw Materials Lists

Table 86. Raw Materials Key Suppliers Lists

Table 87. Antisense Oligonucleotides Drugs for ATTR Distributors List

Table 88. Antisense Oligonucleotides Drugs for ATTR Customers List

Table 89. Antisense Oligonucleotides Drugs for ATTR Market Trends

Table 90. Antisense Oligonucleotides Drugs for ATTR Market Drivers

Table 91. Antisense Oligonucleotides Drugs for ATTR Market Challenges

Table 92. Antisense Oligonucleotides Drugs for ATTR Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Product Picture of Antisense Oligonucleotides Drugs for ATTR

Figure 2. Global Antisense Oligonucleotides Drugs for ATTR Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Antisense Oligonucleotides Drugs for ATTR Market Share by Type: 2023 & 2030

Figure 4. Inotersen Product Picture

Figure 5. Eplontersen Product Picture

Figure 6. Other Product Picture

Figure 7. Global Antisense Oligonucleotides Drugs for ATTR Market Value by Application (2024-2030) & (US$ Million)

Figure 8. Global Antisense Oligonucleotides Drugs for ATTR Market Share by Application: 2023 & 2030

Figure 9. Hospital and Clinic

Figure 10. Retail Pharmacies

Figure 11. Other

Figure 12. Global Antisense Oligonucleotides Drugs for ATTR Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Antisense Oligonucleotides Drugs for ATTR Market Size (2019-2030) & (US$ Million)

Figure 14. Global Antisense Oligonucleotides Drugs for ATTR Sales (2019-2030) & (K Units)

Figure 15. Global Antisense Oligonucleotides Drugs for ATTR Average Price (US$/Unit) & (2019-2030)

Figure 16. Antisense Oligonucleotides Drugs for ATTR Report Years Considered

Figure 17. Antisense Oligonucleotides Drugs for ATTR Sales Share by Manufacturers in 2023

Figure 18. Global Antisense Oligonucleotides Drugs for ATTR Revenue Share by Manufacturers in 2023

Figure 19. Global 5 and 10 Largest Antisense Oligonucleotides Drugs for ATTR Players: Market Share by Revenue in Antisense Oligonucleotides Drugs for ATTR in 2023

Figure 20. Antisense Oligonucleotides Drugs for ATTR Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 21. Global Antisense Oligonucleotides Drugs for ATTR Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2019-2030)

Figure 23. North America Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2019-2030)

Figure 24. United States Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2019-2030)

Figure 27. Europe Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2019-2030)

Figure 28. Germany Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Region (2019-2030)

Figure 35. China Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2019-2030)

Figure 43. Mexico Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Colombia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Sales Market Share by Country (2019-2030)

Figure 48. Middle East and Africa Antisense Oligonucleotides Drugs for ATTR Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Antisense Oligonucleotides Drugs for ATTR Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Antisense Oligonucleotides Drugs for ATTR by Type (2019-2030)

Figure 53. Global Revenue Market Share of Antisense Oligonucleotides Drugs for ATTR by Type (2019-2030)

Figure 54. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Antisense Oligonucleotides Drugs for ATTR by Application (2019-2030)

Figure 56. Global Revenue Market Share of Antisense Oligonucleotides Drugs for ATTR by Application (2019-2030)

Figure 57. Global Antisense Oligonucleotides Drugs for ATTR Price (US$/Unit) by Application (2019-2030)

Figure 58. Antisense Oligonucleotides Drugs for ATTR Value Chain

Figure 59. Antisense Oligonucleotides Drugs for ATTR Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Antisense Oligonucleotide Therapy for the Nervous System Market Research Report 2024

Global ASO based Drug Market Research Report 2024

Global Antisense Oligonucleotides based Therapeutics Market Research Report 2024

Global Antisense ODN Market Research Report 2024

Global Antisense Oligonucleotides ASO Drug Market Research Report 2024

Global Antisense Oligonucleotides ASOs Drugs Market Research Report 2024

Global Antisense Oligonucleotide Service Market Research Report 2025

Global Antisense Oligonucleotides Market Research Report 2024

Global Antisense oligonucleotides ASO Drug and siRNA Drug Market Research Report 2024

Antisense Oligonucleotide ASO Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drugs for Transthyretin Amyloid Cardiomyopathy Market Research Report 2024

Global Treatment of Hereditary Transthyretin Amyloid Neuropathy ATTRv PN Market Research Report 2024

Global Oligonucleotide Therapeutics Market Research Report 2024

Transthyretin amyloid cardiomyopathy ATTR CM Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oligonucleotide Oligo Drugs Market Research Report 2024

Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibody Oligonucleotide Conjugates AOC Drug Market Research Report 2024

Global Oligonucleotide Drugs ONs Market Research Report 2025

Global CNS Specific Antisense Oligonucleotides Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions